Form 4: Ardelrx, Inc. Officer Elizabeth Grammer Sells 86,000 Shares Under 10b5-1 Plan

Elizabeth Grammer, Chief Legal and Administrative Officer of Ardelrx, Inc., sold 86,000 shares of common stock at an average price of $7.7323 per share on March 20, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On March 20, 2024, Elizabeth Grammer, the Chief Legal and Administrative Officer of Ardelrx, Inc., sold 86,000 shares of the company's common stock.
• The sale was executed at a weighted average price of $7.7323 per share, with individual trades occurring between $7.65 and $7.92.
• The transaction was conducted under a 10b5-1 trading plan adopted on December 20, 2023.
• Following the transaction, Grammer directly owns 312,993 shares of Ardelrx, Inc.
• The reporting person has undertaken to provide full information regarding the number of shares sold at each respective price within the range set forth in the footnote upon request to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine transaction under a pre-arranged trading plan. There's no indication of positive or negative implications for the company's performance.

Risks

• Sales by company officers can sometimes be perceived negatively by the market, although this sale was conducted under a pre-arranged 10b5-1 trading plan.

Industry Context

Insider sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares without raising concerns about trading on non-public information.

Stakeholder Impact

• The sale could have a minor impact on shareholders if it creates downward pressure on the stock price, although the 10b5-1 plan mitigates concerns about insider information.

Key Dates